Corrigendum to "MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42" [Biochem. Biophys. Res. Commun. 472 (1) (2016) 262-9]
Biochem Biophys Res Commun. 2020 Jan 8;521(2):541-543.
doi: 10.1016/j.bbrc.2019.10.189.
Epub 2019 Nov 8.
1 School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
2 Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
3 School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China. Electronic address: xitao18@hotmail.com.